Stargardt Disease Therapeutics Market Estimated to Witness High Growth Owing to Rising Prevalence of Genetic Disorder
Stargardt disease therapeutics are used for the treatment of Stargardt disease which is a genetic retinal disorder that causes central vision loss. The disease is commonly associated with mutations in the ABCA4 gene, which usually leads to accumulation of lipofuscin in the retina. The key products associated with the market include regenerative the